InvestorsHub Logo
Followers 57
Posts 11397
Boards Moderated 0
Alias Born 02/09/2009

Re: None

Thursday, 02/04/2016 8:33:18 AM

Thursday, February 04, 2016 8:33:18 AM

Post# of 30990
Inhibition, STAT3, Inflammation, Phase I Clinical Trial, Europe

Rock Creek Pharmaceuticals Announces Inhibition of STAT 3 Activation, A Key Marker of Inflammation, In Phase I Clinical Trial in Europe

http://finance.yahoo.com/news/rock-creek-pharmaceuticals-announces-inhibition-134500908.html

Feb 3, 2016

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.